Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ARIPIPRAZOLE vs ASCIMINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ARIPIPRAZOLE vs ASCIMINIB: Safety Overview

Metric ARIPIPRAZOLE ASCIMINIB
Total FAERS Reports 66,335 2,330
Deaths Reported 3,863 269
Death Rate 5.8% 11.5%
Hospitalizations 20,713 426
Average Patient Age 39.1 yrs 61.2 yrs
% Female Patients 55.7% 50.5%
FDA Approval Date Apr 15, 2025 Apr 18, 2024
Manufacturer NCS HealthCare of KY, LLC dba Vangard... Novartis Pharmaceuticals Corporation
Route ORAL ORAL
Marketing Status Prescription Prescription